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Microbial activityAbstract In this study we synthesized the new compounds containing bis-1,3,4-thiadiazole
3(A–D)n from many reaction steps (cyclization, diazotization and etheriﬁcation respectively). The
compounds have been characterized by melting point, FT-IR and 1H NMR data. All the synthe-
sized compounds have been evaluated in vitro for their antimicrobial activities against several
microbes like: Escherichia coli, Klebsiellia pneumonia, Pseudomonas aeruginosa, Serratia marscens
and Staphylococcus aureus and show that some of these compounds have very good antibacterial
activity.
ª 2010 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
The aminothiadiazoles have occupied an important place in
drug industry. 1,3,4-Thiadiazole has wide applications in many
ﬁelds. The earliest uses were in the pharmaceutical area as anti-
bacterial drugs (Vasoya et al., 2005).The 1,3,4-thiadiazole ring system has incorporated many
substances with antibacterial, ameobicide, parasiticide and
antifungal activities (Farzin and Rahil, 2008; Mohd et al.,
2009). In addition, it was reported that 1,3,4-thiadiazole exhi-
bit various biological activities possibly due to the presence of
the N‚C–S moiety (Holla et al., 2002).
It was also know that 3- and 4-substituted pyridines
recorded pronounced antimicrobial activity such as isonicoti-
nic acid hydrazide, which remains one of the most effective
antibiotics against tuberculosis. Also, sulphanilamides effec-
tiveness extends to acute chronic Gram negative and Gram
positive infections. For example, sulfa pyridine is a chemo-
therapeutic agent for the treatment of pneumococcal and
other bacterial infections (Osama and Salwa, 2005). There
688 I.H.R. Tomi et al.are many interesting studies on the biological activity of 2-
amino-1,3,4-thiadiazole. Mohammad et al. (2009) found
some derivatives of aminothiadiazole (I) having good
anticonvulsant activity in the range of 33–100% in
comparison to phenytoin, which completely inhibited the
convulsions produced by an electroconvulsometer in albino
mice.
N
NN
S NH
R
R= H, O-CH3, P-CH3, O-OCH3, P-Cl
(I)
Ranjina et al. (2006) synthesized a number of derivatives of
aminothiadiazole containing 4-pyridyl and oxothiazolidin
moieties in the same molecules (II).
N
NN
S
N
S
Ar
R
Ar = 4- OCH3C6H4, 4-ClC6H4, 3,4,5-OCH3C6H2, 3-NO2C6H4, 4-NO2C6H4, C6H5, 2-Furyl, 
4-(CH3)2NHC6H4, R= phthalimidoxy.
O
O
(II)
He found that all the compounds have good antimicrobial
activity but the compounds in which a nitro group is present at
the Meta and Para position of the aryl ring, respectively, pos-
sess stronger antibacterial activity than others.
In this study, we designed new azo compounds containing
bis-1,3,4-thiadiazole ring derived from nicotinic and isonicoti-
nic acids in the same molecules. This type of combination and
rebuilding of these heterocyclic compounds are expected to
have high biological activity largely as antimicrobial agents
and we compared the biological activity results of these com-
pounds with the analogous containing the same structural
units except replacing of the nicotinic and isonicotinic moieties
with phenyl and cyclohexyl rings.
2. Experimental
2.1. Materials and physical measurements
All starting materials and solvents were purchased from
Aldrich and Fluka and used without further puriﬁcation. Melt-
ing points were determined on Electro-thermal capillary appa-
ratus and are uncorrected. The FT-IR spectra were obtained
using SHIMADZU model FT-IR-8400S. 1H NMR spectra
were obtained on BRUKER model Ultra shield 300 MHz
spectrophotometer in DMSO-d6 solution with the TMS asthe internal standard. Note: in some 1H NMR spectra, the
peaks at d 2.5 and 3.35 are for the solvent (DMSO-d6) and dis-
solved water in (DMSO-d6), respectively.
2.2. Preparation methods and physical data of synthesized
compounds 1(A–D)–3(A–D)
2.2.1. General procedure for preparation of 2-amino-5-
(substituted)-1,3,4-thiadiazole 1(A–D)
A mixture of the corresponding carboxylic acid (10 mmol), thi-
osemicarbazide (0.91 g, 10 mmol) and phosphorous oxychlo-
ride (5 mL) was gently reﬂuxed for 3 h. After cooling, water
(25 mL) was added slowly and the reaction mixture was
reﬂuxed for 3 h and ﬁltered. The solution was neutralized with
concentrated potassium hydroxide solution and the precipitate
was ﬁltered and recrystallized from ethanol.
2.2.1.1. 2-Amino-5-(3-pyridyl)-1,3,4-thiadiazole (1A). This
compound was obtained as a pale yellow powder, yield
(69%), mp > 300 C; FT-IR (KBr disk, cm1) 3308 and
3168 (NH2), 1645 (C‚N) cm
1; 1H NMR (DMSO-d6,
300 MHz, d) 9.19 (s, 1H, a-H, pyridine), 8.95 (d, 1H, d-H, pyr-
idine), 8.62 (t, 1H, c-H, pyridine), 8.12 (d, 1H, b-H, pyridine),
7.55 (s, 2H, NH2).
2.2.1.2. 2-Amino-5-(4-pyridyl)-1,3,4-thiadiazole (1B). This
compound was obtained as a yellow powder, yield (74%),
mp 239–240 C; FT-IR (KBr disk, cm1) 3297 and 3123
(NH2), 1641 (C‚N) cm
1; 1H NMR (DMSO-d6, 300 MHz,
d) 8.70 (d, 2H, HC‚N, pyridine), 7.85 (d, 2H, HC‚C, pyri-
dine), 7.75 (s, 2H, NH2).
2.2.1.3. 2-Amino-5-(4-phenyl)-1,3,4-thiadiazole (1C). This
compound was obtained as an off white powder, yield
(82%), mp 220–222 C; FT-IR (KBr disk, cm1) 3320 and
3156 (NH2), 1631 (C‚N) cm
1; 1H NMR (DMSO-d6,
300 MHz, d) 7.78–7.47 (m, 5H, Ar–H), 7.43 (s, 2H, NH2).
2.2.1.4. 2-Amino-5-(4-cyclohexyl)-1,3,4-thiadiazole (1D). This
compound was obtained as a white powder, yield (91%), mp
238–240 C; FT-IR (KBr disk, cm1) 3302 and 3117 (NH2),
1633 (C‚N) cm1; 1H NMR (DMSO-d6, 300 MHz, d) 6.99
(s, 2H, NH2), 1.99–1.15 (m, 11H, cyclohexyl).
2.2.2. General procedure for preparation of 2-(p-hydroxyphenyl-
azo)-5-(substituted)-1,3,4-thiadiazole 2(A–D)
Compounds 1(A–D) (1.78 mmol) were dissolved by heating
and stirring in (8 mL) of 85% phosphoric acid. The solution
was cooled to 0 C in an ice bath, and then concentrated nitric
acid (4 mL) and a solution of sodium nitrite (0.13 g,
1.87 mmol) in (2 mL) of water was added. The mixture was
stirred vigorously and maintained at below 5 C during
10 min. Afterwards a solution of phenol (0.17 g, 1.78 mmol)
in (0.5 mL) water was added dropwise with stirring. The mix-
ture was poured into cold water (100 mL). The precipitate
solid was ﬁltered, washed several times with water and recrys-
tallized from ethanol.
2.2.2.1. 2-(p-Hydroxyphenyl-azo)-5-(3-pyridyl)-1,3,4-thiadia-
zole 2(A). This compound was obtained as a dark red powder,
yield (71%), mp 246–248 C; FT-IR (KBr disk, cm1) 3450–
3095 (broad O–H group), 1432 (N‚N) cm1; 1H NMR
Synthesis, characterization and biological activities of some azo derivatives 689(DMSO-d6, 300 MHz, d) 9.29 (s, 1H, a-H, pyridine), 8.83 (d,
1H, d-H, pyridine), 8.57 (t, 1H, c-H, pyridine), 8.51 (s, 1H,
OH), 8.20 (d, 1H, b-H, pyridine), 7.71 (d, 2H, Ar–H), 7.35
(d, 2H, Ar–H).
2.2.2.2. 2-(p-Hydroxyphenyl-azo)-5-(4-pyridyl)-1,3,4-thiadia-
zole 2(B). This compound was obtained as a dark brown pow-
der, yield (77%), mp > 300 C; FT-IR (KBr disk, cm1) 3431–
3083 (broad O–H group), 1425 (N‚N) cm1; 1H NMR
(DMSO-d6, 300 MHz, d) 8.55 (s, 1H, OH), 8.35 (d, 2H,
HC‚N, pyridine), 7.93 (d, 2H, HC‚C, pyridine), 7.46 (d,
2H, Ar–H), 6.97 (d, 2H, Ar–H).
2.2.2.3. 2-(p-Hydroxyphenyl-azo)-5-(phenyl)-1,3,4-thiadiazole
2(C). This compound was obtained as a brown powder, yield
(86%), mp 196–198 C; FT-IR (KBr disk, cm1) 3553-3112
(broad O–H group), 1417 (N‚N) cm1; 1H NMR (DMSO-
d6, 300 MHz, d) 8.59 (s, 1H, OH), 7.98–8.12 (m, 5H, Ar–H),
7.39 (d, 2H, Ar–H), 7.05 (d, 2H, Ar–H).
2.2.2.4. 2-(p-Hydroxyphenyl-azo)-5-(cyclohexyl)-1,3,4-thiadi-
azole 2(D). This compound was obtained as a deep orange
powder, yield (71%), mp 118–121 C; FT-IR (KBr disk,
cm1) 3439-3097 (broad O–H group), 1397 (N‚N) cm1;
1H NMR (DMSO-d6, 300 MHz, d) 8.49 (s, 1H, OH), 8.27 (d,
2H, Ar–H), 7.30 (d, 2H, Ar–H), 2.08–1.13 (m, 11H,
cyclohexyl).
2.2.3. General procedure for preparation of alkane-bis-a-x-[2-
(p-alkoxyphenyl-azo-)-5-(substituted)]-1,3,4-thiadiazole
3(A–D)n
These compounds were synthesized by alkylation’s of
dyes 2(A–D) using the described method by Vyas and
Shah (1963). 2-(p-Hydroxyphenyl-azo)-5-(substituted)-1,3,4-
thiadiazole 2(A–D) (10 mmol), appropriate 1,n-dibromo or
iodo alkane (6 mmol) and anhydrous potassium carbonate
(15 mmol) were added to dry acetone (10 mL). The reaction
mixture was reﬂuxed on a water bath for 24 h. Then it was
added to ice-cold water. The crude solid product thusTable 1 Physical properties and FT-IR data of compounds 3(A–D
Comp. No. Color Mp C Yie
3(A)1 Red >300 43
3(A)2 Dark red >300 56
3(A)3 Dark red 289–291 41
3(A)4 Red 275–277 39
3(A)5 Dark red 281–285 57
3(B)1 Brown >300 33
3(B)2 Brown >300 42
3(B)3 Dark brown >300 52
3(B)4 Brown >300 56
3(B)5 Dark brown 285–288 57
3(C)1 Brown >300 37
3(C)2 Brown >300 48
3(C)3 Light brown 290–292 33
3(C)4 Dark brown 277–280 32
3(C)5 Brown 269–271 48
3(D)1 Deep orange >300 42
3(D)2 Deep orange 288–289 46
3(D)3 Orange 238–242 59
3(D)4 Orange 200–202 33
3(D)5 Brown 194–197 57obtained was triturated with cold 5% aqueous sodium
hydroxide solution for 30 min so as to remove unreacted azo
dyes and was washed with water several times. The products
obtained after ﬂirtation were ﬁnally crystallized using
ethanol. The physical properties and FT-IR spectral data of
all compounds 3(A–D)n are listed in Table 1.
2.2.3.1. Methane-bis-a-x-[2-(p-alkoxyphenyl)-azo-)-5-(3-pyri-
dyl)]-1,3,4-thiadiazole 3(A)1.
1H NMR (DMSO-d6, 300 MHz,
d) 9.18 (s, 2H, a-H, pyridine), 8.72 (d, 2H, d-H, pyridine), 8.37
(t, 2H, c-H, pyridine), 8.25 (d, 2H, b-H, pyridine), 7.76 (d, 4H,
Ar–H), 7.58 (d, 4H, Ar–H), 6.46 (s, 2H, CH2).
2.2.3.2. Ethane-bis-a-x-[2-(p-alkoxyphenyl)-azo-)-5-(4-pyri-
dyl)]-1,3,4-thiadiazole 3(B)2.
1H NMR (DMSO-d6, 300 MHz,
d) 8.58 (d, 4H, HC‚N, pyridine), 7.97 (d, 4H, HC‚C, pyri-
dine), 7.39 (d, 4H, Ar–H), 7.01 (d, 4H, Ar–H), 4.19 (t, 4H,
CH2).
2.2.3.3.Butane-bis-a-x-[2-(p-alkoxyphenyl)-azo-)-5-(phenyl)]-
1,3,4-thiadiazole 3(C)4.
1H NMR (DMSO-d6, 300 MHz, d)
7.81–8.23 (m, 10H, Ar–H), 7.22 (d, 4H, Ar–H), 7.02 (d, 4H,
Ar–H), 4.07 (t, 4H, OCH2CH2), 2.12 (m, 4H, OCH2CH2).
2.2.3.4. Propane-bis-a-x-[2-(p-alkoxyphenyl)-azo-)-5-(cyclo-
hexyl)]-1,3,4-thiadiazole 3(D)3.
1H NMR (DMSO-d6,
300 MHz, d) 8.21 (d, 4H, Ar–H), 7.34 (d, 4H, Ar–H), 4.21
(t, 4H, OCH2) 2.32–1.09 (m, 24H, cyclohexyl and
OCH2CH2CH2O).
3. Results and discussion
3.1. Synthesis
Scheme 1 outlines the synthetic sequences employed in our lab-
oratories for the preparation of series 3(A–D)n.
2-Amino-5-(substituted)-1,3,4-thiadiazole 1(A–D) were
prepared in good yields by the reaction of the corresponding
carboxylic acids with thiosemicarbazide in the presence of)n.
ld % tC–H Aliph. tC–O–C asym. and sym.
2920, 2877 1255, 1051
2929, 2871 1261, 1044
2919, 2866 1266, 1053
2932, 2880 1257, 1047
2927, 2858 1247, 1049
2937, 2870 1247, 1046
2941, 2866 1251, 1061
2936, 2858 1259, 1043
2932, 2867 1244, 1045
2928, 2856 1263, 1074
2921, 2868 1266, 1081
2935, 2855 1259, 1077
2924, 2854 1248, 1070
2937, 2862 1242, 1060
2943, 2871 1249, 1071
2929, 2854 1253, 1049
2934, 2859 1261, 1039
2941, 2844 1267, 1050
2929, 2852 1257, 1024
2931, 2857 1263, 1033
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690 I.H.R. Tomi et al.phosphorous oxychloride. The proposed mechanism of this
reaction was described by Emad et al. (2009) and was shown
in Scheme 2.
The FT-IR spectra of compounds 1(A–D) indicated the
presence of a C‚N function (1631–1645 cm1) and two bands
at (3320–3297 cm1) and (3168–3117 cm1), which could be
attributed to asymmetric and symmetric stretching vibrations
of NH2 group. The
1H NMR spectra of these compounds
showed a singlet at d (6.9–7.7) ppm due to the NH2 protons.
Fig. 1 showed the 1H NMR spectra of compounds 1(A),
1(C) and 1(D).The azo compounds 2(A–D) were synthesized by diazotiza-
tion of compounds 1(A–D) and coupling with phenol by fol-
lowing the method reported by Erlenmeyer and Ueberwasser
(1942). This reaction may be outlined as follows in Scheme 3
(John, 2004).
The characteristic FT-IR absorption bands of azo com-
pounds 2(A–D) showed the disappearance of two absorption
bands due to NH2 group together with the appearance
of a broad peak between 3550 and 3085 cm1 due to the inter-
molecular hydrogen bonding of phenolic O–H bond for com-
pounds 2(A–D) (Prajapati and Bonde, 2006). It also shows a
Figure 1 1H NMR spectra of compounds 1(A) (a), 1(C) (b) and 1(D) (c).
Synthesis, characterization and biological activities of some azo derivatives 691band at 1432–1397 cm1 which is due to the N‚N bond
(Silverstein and Webster, 1996). The 1H NMR results of azocompounds 2(A–D) showed a singlet peak at d (8.49–8.59)
that could be assigned to the protons of the phenolic
Figure 2 1H NMR spectra of compounds 2(A) (a), 2(B) (b), 2(C) (c) and 2(D) (d).
692 I.H.R. Tomi et al.hydroxyl group. Fig. 2 showed the 1H NMR spectra of
compounds 2(A–D).
Condensation of azo compounds 2(A–D) with a-x dibromo
or iodo alkane in dry acetone in the presence of anhydrous
K2CO3 gave di ethers, series 3(A–D)n. The FT-IR spectra of
compounds 3(A–D)n showed the C–H stretching absorption
band near (2919 and 2880 cm1) and C–O–C stretching band,
asymmetrical and symmetrical near 1267 cm1 and 1024 cm1,
respectively. Fig. 3 shows the 1H NMR spectrum of compound
3(A)1, for example, of all compounds 3(A–D)n. The physical
properties and FT-IR spectral data of all compounds 3(A–
D)n are listed in Table 1.
3.2. Biological evaluation
All the synthesized compounds 3(A–D)n have been screened
for antibacterial activities using cup-plate agar diffusion
method (Barry, 1976) by measuring the inhibition zone in
mm. Azithromycin (300 lg/lL) was used as a standard drug
for antibacterial activity. The compounds were screened for
antibacterial activity against Escherichia coli, Klebsiellia
pneumonia, Pseudomonas aeruginosa, Serratia marscens and
Staphylococcus aureus in Muller Hinton agar. Thesesterilized agar media were poured into Petri-dishes and
allowed to solidify. On the surface of the media microbial
suspensions were spread with the help of a sterilized
triangular loop. A stainless steel cylinder of 12 mm diameter
(pre-sterilized) was used to bore cavities. All the synthesized
compounds (300 lg/lL) were placed serially in cavities with
the help of a micropipette and allowed to diffuse for one hr.
DMF was used as a solvent for all compounds (as a stock)
then the concentration (300 lg/lL) was prepared using sterile
distilled water. These plates were incubated at 37 C for 48
hr. The zone of inhibition observed around the cups after
respective incubation was measured and percent inhibition of
the compounds was calculated. The results are presented in
Table 2.
When we show the data of (inhibition zone %) of all com-
pounds 3(A–D)n in Table 2 we observe some important results:
the ﬁrst that the compounds 3(B)n, 3(C)n and 3(D)n showed
good activity against E. coli, while only the compounds
3(A)n showed good activity against K. pneumonia. Also we
showed that some of the compounds 3(A–D)n have good activ-
ity against S. aureus, while all compounds 3(A–D)n did not
show any antibacterial activity against P. aeruginosa and S.
marscens. When we show the percentage of inhibition zone
Figure 3 1H NMR spectrum of compound 3(A)1.
Table 2 Antibacterial activities of compounds 3(A–D)n.
Comp. No. Escherichia coli Klebsiellia pneumonia Pseudomonas aeruginosa Serratia marscens Staphylococcus aureus
Zone of
inhibition
(mm)
%
Inhibition
Zone of
inhibition
(mm)
%
Inhibition
Zone of
inhibition
(mm)
%
Inhibition
Zone of
inhibition
(mm)
%
Inhibition
Zone of
inhibition
(mm)
%
Inhibition
3(A)1 0 0 35 159.09 0 0 0 0 34 113.33
3(A)2 0 0 35 159.09 0 0 0 0 35 116.67
3(A)3 0 0 35 159.09 0 0 0 0 0 0
3(A)4 0 0 35 159.09 0 0 0 0 0 0
3(A)5 0 0 35 159.09 0 0 0 0 0 0
3(B)1 27 135.00 0 0 0 0 0 0 35 116.67
3(B)2 30 150.00 0 0 0 0 0 0 0 0
3(B)3 35 175.00 0 0 0 0 0 0 0 0
3(B)4 34 170.00 0 0 0 0 0 0 14 46.67
3(B)5 50 250.00 0 0 0 0 0 0 0 0
3(C)1 10 50.00 0 0 0 0 0 0 0 0
3(C)2 15 75.00 0 0 0 0 0 0 35 116.67
3(C)3 20 100.00 0 0 0 0 0 0 0 0
3(C)4 30 150.00 0 0 0 0 0 0 0 0
3(C)5 35 175.00 0 0 0 0 0 0 36 120.00
3(D)1 30 150.00 0 0 0 0 0 0 0 0
3(D)2 25 125.00 0 0 0 0 0 0 0 0
3(D)3 25 125.00 0 0 0 0 0 0 0 0
3(D)4 25 125.00 0 0 0 0 0 0 30 100.00
3(D)5 25 125.00 0 0 0 0 0 0 35 116.67
St. 20 100 22 100 28 100 35 100 30 100
St., standard (Azithromycin).
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bacterial activity of these compounds increase when the chain
of the alkyl group (CH2)n in the central part of the molecules
increase. The derivative 3(B)5 showed potent activity against
E. coli (250.00%), whereas compounds 3(A)1–5 showed the
same inhibition and good activity (159.09%) against K. pneu-
monia. Thus, it is concluded from the screening results that
the most of bis-1,3,4-thiadiazole derivatives 3(A–D)n have
good antibacterial activity more than the standard (Azthromy-cin) against E. coli and some of them against K. pneumonia and
S. aureus also, all compounds 3(A–D)n did not show any
antibacterial activities against P. aeruginosa and S. marscens
at a concentration of 300 lg/lL.
4. Conclusion
Bis-1,3,4-thiadiazole compounds containing the azo moiety
was prepared and structurally characterized using spectro-
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Scheme 3 The mechanism steps of formation of azo compounds 2(A–D).
694 I.H.R. Tomi et al.scopic techniques. The synthetic route started from the cycliza-
tion reaction between thiosemicarbazide and appropriate car-
boxylic acids (nicotinic, isonicotinic, benzoic and cyclohexan
carboxylic acid) in presence of POCl3 followed by the diazoti-
zation reaction between the aminothiadiazole and phenol. The
di azo compounds were prepared by etheriﬁcation of azo com-
pounds with dibromo or iodo alkane in alkali media. Bis-1,3,4-
thiadiazole compounds containing azo moiety have been eval-
uated in vitro for their antimicrobial activities against several
microbes like:E. coli, K. pneumonia, P. aeruginosa, S. marscens
and S. aureus and show that the compounds 3(B)n, 3(C)n and
3(D)n showed good activity against E. coli, while only the com-
pounds 3(A)n showed good activity against K. pneumonia. Also
we showed that some of the compounds 3(A–D)n have good
activity against S. aureus, while all compounds 3(A–D)n did
not show any antibacterial against P. aeruginosa and S.
marscens.
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